Targeting ferroptosis in hepatocellular carcinoma

被引:14
|
作者
Mo, Yuqian [1 ]
Zou, Zhilin [2 ]
Chen, Erbao [3 ]
机构
[1] Guangdong Med Univ, Sch Publ Hlth, Zhanjiang 524023, Guangdong, Peoples R China
[2] Wenzhou Med Univ, Affiliated Eye Hosp, Dept Ophthalmol, Wenzhou, Zhejiang, Peoples R China
[3] Peking Univ, Shenzhen Hosp, Dept Hepatobiliary & Pancreat Surg, Shenzhen 518036, Guangdong, Peoples R China
关键词
Ferroptosis; Hepatocellular carcinoma; Immunotherapy; Immune microenvironment; SUPPRESSOR-CELLS; LIPID-PEROXIDATION; T-CELLS; 1ST-LINE TREATMENT; CANCER; DYSFUNCTION; SORAFENIB; ZIP14; TRANSPORTER; SENSITIVITY;
D O I
10.1007/s12072-023-10593-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a common malignant tumor with complex survival mechanism and drug resistance, resulting in cancer-related high mortality in the world. Ferroptosis represents a form of regulated cell death, typically distinguished by iron-dependent lipid peroxidation. Cancer cells often employ antioxidant defenses to evade the harmful effects of excess iron. Recent research has proposed that directing interventions towards ferroptosis could serve as an effective strategy in curbing the proliferation and invasion of HCC. Immunotherapy has made some preliminary progress in the remodeling of immune microenvironment, but it has not completely inhibited HCC growth, invasion and drug resistance. Furthermore, ferroptosis is widely observed in the formation of immune microenvironment of HCC and mediates the response of many targeted drugs and immunotherapy. Clarifying the role of ferroptosis in these complex processes is expected to provide a new prospect for HCC treatment. In this review, we outline the mechanisms by which HCC develops invasiveness and drug resistance by evading iron-dependent death, and paint a comprehensive landscape of ferroptosis in different cell types in the HCC immune microenvironment.
引用
收藏
页码:32 / 49
页数:18
相关论文
共 50 条
  • [1] Targeting ferroptosis in hepatocellular carcinoma
    Yuqian Mo
    Zhilin Zou
    Erbao Chen
    Hepatology International, 2024, 18 : 32 - 49
  • [2] Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma
    Huang, Ziyue
    Xia, Haoming
    Cui, Yunfu
    Yam, Judy Wai Ping
    Xu, Yi
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (01) : 207 - 218
  • [3] Ferroptosis in hepatocellular carcinoma, from mechanism to effect
    Jiang, Shuang
    Zhang, Guangcong
    Ma, Yanan
    Wu, Dongyu
    Xie, Da
    Zhou, Songke
    Jiang, Xuemei
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [4] Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs
    Chen, Haoran
    Han, Zhongyu
    Su, Junyan
    Song, Xuanliang
    Ma, Qingquan
    Lin, Yumeng
    Ran, Zijin
    Li, Xueping
    Mou, Rongkun
    Wang, Yi
    Li, Dongxuan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] Ferroptosis: a new promising target for hepatocellular carcinoma therapy
    Xu, Qiaoping
    Ren, Lanqi
    Ren, Ning
    Yang, Yibei
    Pan, Junjie
    Zheng, Yu
    Wang, Gang
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (10) : 2615 - 2636
  • [6] Ferroptosis in Cancer Immunotherapy-Implications for Hepatocellular Carcinoma
    Kusnick, Johanna
    Bruneau, Alix
    Tacke, Frank
    Hammerich, Linda
    IMMUNO, 2022, 2 (01): : 185 - 217
  • [7] New perspectives on ferroptosis and its role in hepatocellular carcinoma
    Cong, Tianhao
    Luo, Yingen
    Fu, Yan
    Liu, Yu
    Li, Yujie
    Li, Xiao
    CHINESE MEDICAL JOURNAL, 2022, 135 (18) : 2157 - 2166
  • [8] The Critical Role of Ferroptosis in Hepatocellular Carcinoma
    Pan, Fan
    Lin, Xinrong
    Hao, Liping
    Wang, Ting
    Song, Haizhu
    Wang, Rui
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [9] Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
    Liao, Hao
    Shi, Juanyi
    Wen, Kai
    Lin, Jianhong
    Liu, Qinghua
    Shi, Bingchao
    Yan, Yongcong
    Xiao, Zhiyu
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 985 - 996
  • [10] Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
    Li, Lanqing
    Wang, Xiaoqiang
    Xu, Haiying
    Liu, Xianqiong
    Xu, Kang
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9